세계 일회용 바이오 리액터 시장 조사 보고서 : 산업 분석, 규모, 점유율, 성장, 동향 예측(2024-2032년)

The global demand for Single-Use Bioreactor Market is presumed to reach the market size of nearly USD 16.13 Billion by 2032 from USD 3.5 Billion in 2023 with a CAGR of 18.5% under the study period 2024 - 2032.

Single-use bioreactors are disposable bioprocessing vessels used to produce biopharmaceuticals and vaccines. Unlike traditional stainless steel bioreactors, these bioreactors are made from flexible plastic materials and are intended for single-use applications, removing the need for cleaning and sterilization between batches. These bioreactors offer several advantages, including reduced cross-contamination risks, faster turnaround times, and lower operating costs. It has various sizes and configurations to accommodate different production scales and cell culture requirements. They play a crucial role in the biopharmaceutical industry, enabling flexible and cost-effective manufacturing of biologics and therapeutics.

Market Dynamics

The increasing adoption of single-use bioreactors in biopharmaceutical manufacturing is fueled by their advantages over traditional stainless steel bioreactors, including reduced contamination risks, faster turnaround times, and lower operational costs. As the biopharmaceutical industry continues to expand, driven by the growing demand for biologics and personalized medicine, there is a heightened need for flexible and scalable manufacturing solutions, driving market demand for single-use bioreactors. Moreover, the advancements in single-use bioreactor technology, such as improved cell culture performance, enhanced process control, and compatibility with a broad range of cell lines and culture media, further drive market growth.

Additionally, the increasing outsourcing of biopharmaceutical production to contract manufacturing organizations (CMOs) and the growing trend of decentralized manufacturing facilities are creating new growth opportunities for manufacturers. Furthermore, the regulatory approvals and guidelines supporting the use of single-use systems in biopharmaceutical manufacturing and the industry's focus on sustainability and reducing environmental impact are driving market adoption. Moreover, the ongoing research and development efforts to expand the application areas, such as cell therapy manufacturing and regenerative medicine, are expected to drive market growth further. However, stringent regulatory requirements and concerns regarding contamination risks may challenge the market growth in the coming years.

This detailed market study is centered on the data obtained from multiple sources and is analyzed using numerous tools including porter's five forces analysis, market attractiveness analysis and value chain analysis. These tools are employed to gain insights of the potential value of the market facilitating the business strategists with the latest growth opportunities. Additionally, these tools also provide a detailed analysis of each application/product segment in the global market of single-use bioreactor.

Market Segmentation

The broad single-use bioreactor market has been sub-grouped into product type, type of molecule, type of cell, type, application and end-user. The report studies these subsets with respect to the geographical segmentation. The strategists can gain a detailed insight and devise appropriate strategies to target specific market. This detail will lead to a focused approach leading to identification of better opportunities.

By Product Type

• Single-Use Bioreactors System
• Single-Use Media Bags
• Single-Use Filtration Assemblies
• Others

By Type Of Cell

• Bacteria Cells
• Yeast Cells
• Mammalian Cells
• Others

By Type

• Stirred-Tank Single Use Bioreactor
• Wave-Induced Single Use Bioreactor
• Bubble Column Single Use Bioreactor
• Others

By Application

• Process Development
• Research And Development (R&D)
• Bioproduction

By Molecule Type

• Monoclonal Antibodies
• Vaccine
• Stem Cells
• Gene Modified Cells
• Others

By End-User

• CROs & CMOs
• Pharmaceutical & Biotechnology Companies
• Academic & Research Institute
• Regional Analysis
• Furthermore, the report comprises of the geographical segmentation which mainly focuses on current and forecast demand for single-use bioreactor in North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. The report further focuses on demand for individual application segments in all the regions.
• The report also covers detailed competitive landscape including company profiles of key players operating in the global market. The key players in the Single-Use Bioreactor market includes Merck KGaA, Cesco Bioengineering Co., Ltd., GENERAL ELECTRIC, Solida Biotechnology GmbH, Applikon Biotechnology, Danaher, Celltainer, Pierre Guerin, Cellexus Ltd, Esco Micro Pte Ltd., Thermo Fisher Scientific, Sartorius AG, Eppendorf AG, Distek, Inc., PBS Biotech, Inc.. An in-depth view of the competitive outlook includes future capacities, key mergers & acquisitions, financial overview, partnerships, collaborations, new product launches, new product developments and other developments with information in terms of H.Q.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

TABLE OF CONTENTS

1. PREFACE

• 1.1. Report Description
  • 1.1.1 Objective
  • 1.1.2 Target Audience
  • 1.1.3 Unique Selling Proposition (USP) & offerings
• 1.2. Research Scope
• 1.3. Research Methodology
  • 1.3.1 Market Research Process
  • 1.3.2 Market Research Methodology

2. EXECUTIVE SUMMARY

• 2.1. Highlights of Market
• 2.2. Global Market Snapshot

3. SINGLE-USE BIOREACTOR - INDUSTRY ANALYSIS

• 3.1. Introduction - Market Dynamics
• 3.2. Market Drivers
• 3.3. Market Restraints
• 3.4. Opportunities
• 3.5. Industry Trends
• 3.6. Porter's Five Force Analysis
• 3.7. Market Attractiveness Analysis
  • 3.7.1 Market Attractiveness Analysis By Product Type
  • 3.7.2 Market Attractiveness Analysis By Type Of Cell
  • 3.7.3 Market Attractiveness Analysis By Type
  • 3.7.4 Market Attractiveness Analysis By Application
  • 3.7.5 Market Attractiveness Analysis By Molecule Type
  • 3.7.6 Market Attractiveness Analysis By End-User
  • 3.7.7 Market Attractiveness Analysis By Region

4. VALUE CHAIN ANALYSIS

• 4.1. Value Chain Analysis
• 4.2. Raw Material Analysis
  • 4.2.1 List of Raw Materials
  • 4.2.2 Raw Material Manufactures List
  • 4.2.3 Price Trend of Key Raw Materials
• 4.3. List of Potential Buyers
• 4.4. Marketing Channel
  • 4.4.1 Direct Marketing
  • 4.4.2 Indirect Marketing
  • 4.4.3 Marketing Channel Development Trend

5. GLOBAL SINGLE-USE BIOREACTOR MARKET ANALYSIS BY PRODUCT TYPE

• 5.1. Overview By Product Type
• 5.2. Historical and Forecast Data
• 5.3. Analysis By Product Type
• 5.4. Single-Use Bioreactors System Historic and Forecast Sales By Regions
• 5.5. Single-Use Media Bags Historic and Forecast Sales By Regions
• 5.6. Single-Use Filtration Assemblies Historic and Forecast Sales By Regions
• 5.7. Others Historic and Forecast Sales By Regions

6. GLOBAL SINGLE-USE BIOREACTOR MARKET ANALYSIS BY TYPE OF CELL

• 6.1. Overview By Type Of Cell
• 6.2. Historical and Forecast Data
• 6.3. Analysis By Type Of Cell
• 6.4. Bacteria Cells Historic and Forecast Sales By Regions
• 6.5. Yeast Cells Historic and Forecast Sales By Regions
• 6.6. Mammalian Cells Historic and Forecast Sales By Regions
• 6.7. Others Historic and Forecast Sales By Regions

7. GLOBAL SINGLE-USE BIOREACTOR MARKET ANALYSIS BY TYPE

• 7.1. Overview By Type
• 7.2. Historical and Forecast Data
• 7.3. Analysis By Type
• 7.4. Stirred-Tank Single Use Bioreactor Historic and Forecast Sales By Regions
• 7.5. Wave-Induced Single Use Bioreactor Historic and Forecast Sales By Regions
• 7.6. Bubble Column Single Use Bioreactor Historic and Forecast Sales By Regions
• 7.7. Others Historic and Forecast Sales By Regions

8. GLOBAL SINGLE-USE BIOREACTOR MARKET ANALYSIS BY APPLICATION

• 8.1. Overview By Application
• 8.2. Historical and Forecast Data
• 8.3. Analysis By Application
• 8.4. Process Development Historic and Forecast Sales By Regions
• 8.5. Research And Development (R&D) Historic and Forecast Sales By Regions
• 8.6. Bioproduction Historic and Forecast Sales By Regions

9. GLOBAL SINGLE-USE BIOREACTOR MARKET ANALYSIS BY MOLECULE TYPE

• 9.1. Overview By Molecule Type
• 9.2. Historical and Forecast Data
• 9.3. Analysis By Molecule Type
• 9.4. Monoclonal Antibodies Historic and Forecast Sales By Regions
• 9.5. Vaccine Historic and Forecast Sales By Regions
• 9.6. Stem Cells Historic and Forecast Sales By Regions
• 9.7. Gene Modified Cells Historic and Forecast Sales By Regions
• 9.8. Others Historic and Forecast Sales By Regions

10. GLOBAL SINGLE-USE BIOREACTOR MARKET ANALYSIS BY END-USER

• 10.1. Overview By End-User
• 10.2. Historical and Forecast Data
• 10.3. Analysis By End-User
• 10.4. CROs & CMOs Historic and Forecast Sales By Regions
• 10.5. Pharmaceutical & Biotechnology Companies Historic and Forecast Sales By Regions
• 10.6. Academic & Research Institute Historic and Forecast Sales By Regions

11. GLOBAL SINGLE-USE BIOREACTOR MARKET ANALYSIS BY GEOGRAPHY

• 11.1. Regional Outlook
• 11.2. Introduction
• 11.3. North America Sales Analysis
  • 11.3.1 Overview, Historic and Forecast Data Sales Analysis
  • 11.3.2 North America By Segment Sales Analysis
  • 11.3.3 North America By Country Sales Analysis
  • 11.3.4 United States Sales Analysis
  • 11.3.5 Canada Sales Analysis
  • 11.3.6 Mexico Sales Analysis
• 11.4. Europe Sales Analysis
  • 11.4.1 Overview, Historic and Forecast Data Sales Analysis
  • 11.4.2 Europe By Segment Sales Analysis
  • 11.4.3 Europe By Country Sales Analysis
  • 11.4.4 United Kingdom Sales Analysis
  • 11.4.5 France Sales Analysis
  • 11.4.6 Germany Sales Analysis
  • 11.4.7 Italy Sales Analysis
  • 11.4.8 Russia Sales Analysis
  • 11.4.9 Rest Of Europe Sales Analysis
• 11.5. Asia Pacific Sales Analysis
  • 11.5.1 Overview, Historic and Forecast Data Sales Analysis
  • 11.5.2 Asia Pacific By Segment Sales Analysis
  • 11.5.3 Asia Pacific By Country Sales Analysis
  • 11.5.4 China Sales Analysis
  • 11.5.5 India Sales Analysis
  • 11.5.6 Japan Sales Analysis
  • 11.5.7 South Korea Sales Analysis
  • 11.5.8 Australia Sales Analysis
  • 11.5.9 South East Asia Sales Analysis
  • 11.5.10 Rest Of Asia Pacific Sales Analysis
• 11.6. Latin America Sales Analysis
  • 11.6.1 Overview, Historic and Forecast Data Sales Analysis
  • 11.6.2 Latin America By Segment Sales Analysis
  • 11.6.3 Latin America By Country Sales Analysis
  • 11.6.4 Brazil Sales Analysis
  • 11.6.5 Argentina Sales Analysis
  • 11.6.6 Peru Sales Analysis
  • 11.6.7 Chile Sales Analysis
  • 11.6.8 Rest of Latin America Sales Analysis
• 11.7. Middle East & Africa Sales Analysis
  • 11.7.1 Overview, Historic and Forecast Data Sales Analysis
  • 11.7.2 Middle East & Africa By Segment Sales Analysis
  • 11.7.3 Middle East & Africa By Country Sales Analysis
  • 11.7.4 Saudi Arabia Sales Analysis
  • 11.7.5 UAE Sales Analysis
  • 11.7.6 Israel Sales Analysis
  • 11.7.7 South Africa Sales Analysis
  • 11.7.8 Rest Of Middle East And Africa Sales Analysis

12. COMPETITIVE LANDSCAPE OF THE SINGLE-USE BIOREACTOR COMPANIES

• 12.1. Single-Use Bioreactor Market Competition
• 12.2. Partnership/Collaboration/Agreement
• 12.3. Merger And Acquisitions
• 12.4. New Product Launch
• 12.5. Other Developments

13. COMPANY PROFILES OF SINGLE-USE BIOREACTOR INDUSTRY

• 13.1. Top Companies Market Share Analysis
• 13.2. Market Concentration Rate
• 13.3. Merck KGaA
  • 13.3.1 Company Overview
  • 13.3.2 Company Revenue
  • 13.3.3 Products
  • 13.3.4 Recent Developments
• 13.4. Cesco Bioengineering Co. Ltd.
  • 13.4.1 Company Overview
  • 13.4.2 Company Revenue
  • 13.4.3 Products
  • 13.4.4 Recent Developments
• 13.5. GENERAL ELECTRIC
  • 13.5.1 Company Overview
  • 13.5.2 Company Revenue
  • 13.5.3 Products
  • 13.5.4 Recent Developments
• 13.6. Solida Biotechnology GmbH
  • 13.6.1 Company Overview
  • 13.6.2 Company Revenue
  • 13.6.3 Products
  • 13.6.4 Recent Developments
• 13.7. Applikon Biotechnology
  • 13.7.1 Company Overview
  • 13.7.2 Company Revenue
  • 13.7.3 Products
  • 13.7.4 Recent Developments
• 13.8. Danaher
  • 13.8.1 Company Overview
  • 13.8.2 Company Revenue
  • 13.8.3 Products
  • 13.8.4 Recent Developments
• 13.9. Celltainer
  • 13.9.1 Company Overview
  • 13.9.2 Company Revenue
  • 13.9.3 Products
  • 13.9.4 Recent Developments
• 13.10. Pierre GueRin
  • 13.10.1 Company Overview
  • 13.10.2 Company Revenue
  • 13.10.3 Products
  • 13.10.4 Recent Developments
• 13.11. Cellexus Ltd
  • 13.11.1 Company Overview
  • 13.11.2 Company Revenue
  • 13.11.3 Products
  • 13.11.4 Recent Developments
• 13.12. Esco Micro Pte Ltd.
  • 13.12.1 Company Overview
  • 13.12.2 Company Revenue
  • 13.12.3 Products
  • 13.12.4 Recent Developments
• 13.13. Thermo Fisher Scientific
  • 13.13.1 Company Overview
  • 13.13.2 Company Revenue
  • 13.13.3 Products
  • 13.13.4 Recent Developments
• 13.14. Sartorius AG
  • 13.14.1 Company Overview
  • 13.14.2 Company Revenue
  • 13.14.3 Products
  • 13.14.4 Recent Developments
• 13.15. Eppendorf AG
  • 13.15.1 Company Overview
  • 13.15.2 Company Revenue
  • 13.15.3 Products
  • 13.15.4 Recent Developments
• 13.16. Distek Inc.
  • 13.16.1 Company Overview
  • 13.16.2 Company Revenue
  • 13.16.3 Products
  • 13.16.4 Recent Developments
• 13.17. PBS Biotech Inc.
  • 13.17.1 Company Overview
  • 13.17.2 Company Revenue
  • 13.17.3 Products
  • 13.17.4 Recent Developments

Note - In company profiling, financial details and recent developments are subject to availability or might not be covered in the case of private companies